The American Society of Plastic Surgeons (ASPS) has issued a new policy advising its members against performing gender-affirming surgeries on individuals younger than 19 years old. The decision has triggered significant debate and controversy within the field of plastic surgery, especially among experts who were tasked with examining the subject of youth gender surgeries. The ASPS statement was published after extensive review of current scientific evidence and was cited as a move to prioritize patient safety and well-being, given ongoing uncertainties regarding the long-term effects of these procedures on adolescents.
The sudden introduction of the policy statement caught members of the ASPS Youth Gender Surgery Task Force off guard. Several experts, including plastic surgeons, psychiatrists, and medical researchers, had been meeting monthly for nearly nine months to gather evidence and attempt to reach consensus on recommendations for youth gender surgeries. According to an open letter signed by task force members, the ASPS board developed and released its position independently and did not include input from the task force, leading to concerns about transparency and process. Some task force members expressed disappointment that their perspectives may not have been considered by the board, and sought clarification on how the policy decision was made.
The minimum age set at 19 was described by ASPS leaders as a compromise between legal adulthood and the ongoing neurocognitive and psychosocial development that continues for adolescents. Dr. Bob Basu, president of ASPS, explained that the organization’s review of studies on youth gender medicine showed limitations in evidence quality and uncertainty about long-term outcomes. As a result, the ASPS recommended delaying all chest, genital, and facial gender surgeries until patients reach at least 19. Several experts within the task force argued that maturity and ability to consent can vary greatly and suggested that further safeguards or even higher age limits might be needed. Some, like Dr. Steven Montante, advocated for restrictions extending to age 25, citing continued vulnerabilities among young adults.
Concerns about political influences surrounding the policy were raised after communications revealed that ASPS representatives had participated in discussions with a federal agency seeking clarification of organizational positions. However, ASPS leadership maintained that its decision-making process was conducted independently and based on scientific evidence, not politics. The organization emphasized that patient safety and responsible medical practice were the guiding factors behind the new policy.
The shift in ASPS guidelines has been recognized by the Department of Health and Human Services, which praised the move as a protection for vulnerable youth. Meanwhile, the new policy has generated strong reactions from both supporters and critics within the plastic surgery community. Some members are organizing to discuss the policy’s impact on surgeon autonomy and scientific integrity. The ASPS’s decision arrives amid ongoing legal cases and growing public scrutiny over gender-affirming care for minors, marking a significant moment in professional medical guidance and the national debate on youth gender surgeries.
